<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Investorview: Ingredients for growth in life scien...

Industrifonden is an evergreen venture capital fund with headquarters in St...

Read More

Investorview: Why people are key in life science i...

Since it was founded in 1996, European venture capital firm HealthCap has i...

Read More

Investorview: Plugging knowledge gaps to accelerat...

Venture capital firm Hadean Ventures closed its first fund at the end of 20...

Read More

Investorview: Driving early-stage investment in UK...

In March 2018, NCL Technology Ventures launched a £50 million fund to help ...

Read More

Investorview: Committing to social responsibility ...

Swiss venture capital firm MTIP launched its first fund in 2016, achieving ...

Read More

Investor perspective: Sander Slootweg

Looking back at the past year, 2017 has proven to be a pretty successful ye...

Read More

Investorview: Proactively Bridging The Early Stage...

Sinclair Dunlop, Managing Partner at Epidarex Capital Venture capital firm ...

Read More

Investorview: Dr Z Haroon on Julz Co’s recent inve...

Julz Co focuses on healthcare investments across the US, Europe, and Asia-P...

Read More

Investorview - Edward Van Wezel, Managing Director...

We recently sat with Edward Van Wezel, Managing Director and Founder of Bio...

Read More

Investorview - Investing in a Digital Future with ...

Our latest investorview this week is with Christoph Ruedig, Partner at Albi...

Read More

Investorview – Precision Investing with Jay Goth, ...

Our latest investorview is, this week, with Jay Goth, Managing Partner of t...

Read More

Investorview – Zishan Haroon, Chairman & General P...

In a new regular feature for Drugs & Dealers, we’ll be interviewing some of...

Read More

Add Your Response